OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Senate Committee on Health Hears Testimony on Follow-on Biologics | Main | "FDA Law Blog" Goes Live »

March 09, 2007

Pharma News Briefs

  • Bloomberg reports that the topic of reverse payment settlements of Hatch-Waxman litigation came up in a recent Senate hearing.
  • Bloomberg TV interviewed me yesterday about reverse payment settlements.  On Pharma has the video.
  • DUSA Pharmaceuticals announced that a federal court recently lifted the preliminary injunction that prevented River's Edge Pharmaceuticals from selling generic Nicomide, a treatment for acne.
  • Pharmalot has this post on the most recent IMS numbers, which indicate that U.S. prescription drug sales rose 8% last year to $275 billion.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.